Stryker Corp. (NYSE:SYK) received 510(k) clearance from the Food & Drug Administration for its new hip replacement system.
The clearance adds another product to the Kalamazoo, Mich.-based-medical device maker’s portfolio of orthopedic devices, which performed well through the recession.